The Impact of Food on Blood Sugar in People With Type 2 Diabetes (REACT2)

HealthPartners Institute

Status: Completed

Conditions: Type 2 Diabetes

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT01237314

04037-10-C

Details and patient eligibility

About

This study will record the impact of food on blood glucose levels using continuous glucose monitoring (CGM).

The investigators think the impact will improve as medication doses are adjusted. The investigators also think that the impact will differ depending on the type of medication taken.

Enrollment: 46 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Study participants who are consented for the primary study and have not yet done the baseline CGM data collection at week -2-0.

Exclusion criteria

• Study participants who are unable to complete the baseline CGM data collection at week -2-0.
• Study participants who are allergic to or have a food intolerance to any of the foods in the fixed meal

Trial design

46 participants in 3 patient groups

Glargine Group

Description:

After baseline titration of metformin, this group will take glargine along with metformin.

Exenatide Group

Description:

After baseline titration of metformin, this group will take exenatide along with metformin.

Glargine and Exenatide Group

Description:

After baseline titration of metformin, this group will take glargine and exenatide along with metformin.